KUALA LUMPUR, Aug 12 — Pharmaniaga Bhd’s wholly-owned subsidiary Pharmaniaga Lifescience Sdn Bhd (PLS) yesterday signed the Surat Setuju Terima (Tambahan) Perolehan Pembekalan COVID-19 Coronavac Suspension with the government for the purchase of an additional six million doses of fill and finish and imported finished product of COVID-19 vaccine (SST).
In a filing with Bursa Malaysia, Pharmaniaga said the involving parties have also agreed to execute a supplementary agreement to enable PLS to sell, supply, and deliver to the government the number of doses requested.
“The SST and collaboration contemplated therein will serve as a platform for the company to assist the nation in supplying the vaccine.
“It will also help Malaysia to achieve its targeted vaccination rate,” the company said.
Pharmaniaga said the SST would have material effect on the group’s earnings and earnings per share for the financial year ending Dec 31, 2021.